High Dose IV Vitamin C (IVC)
For Oncology Support
Elite Infusion Therapies, is now exclusively offering High-Dose IV Vitamin C (IVC) as a supportive therapy for patients already undergoing cancer treatment. This protocol is not a standalone cancer cure, but may help you better tolerate conventional therapies and support overall patient resilience.
Our approach is informed by protocols such as those from the Riordan Clinic and other integrative oncology practices. (Call to see our protocol.)
Our Protocol & Philosophy
-
We use a systematic, evidence-informed protocol for administering high-dose IVC to cancer patients.
-
Treatments are individualized depending on tumor type, stage, concurrent therapies, patient tolerability, and lab markers.
-
Our goal is to work in concert with your oncologist and medical team, not instead of them.
Key aims of our approach:
-
Support tolerance of chemotherapy / radiation – many patients report reduced side effects.
-
Manage oxidative stress & inflammation – Vitamin C is known to act as an antioxidant at certain doses.
-
Improve quality of life / wellness – supporting energy, immune function, recovery capacity.
-
Strict monitoring and safety – we closely monitor labs and patient responses to adjust dosing.
What to Expect: Treatment Process
Initial Consultation & Evaluation: We review medical history, oncology treatment plan, current labs, and goals.
Baseline Labs & Screening Kidney function, G6PD, oxidative stress markers, etc.
Dosing Plan: We develop a tailored infusion schedule (dose, frequency) suited to your clinical scenario.
Infusion Sessions Administered under supervision, with vital sign monitoring and patient support.
Follow-up & Monitoring: Periodic labs, symptom tracking, and adjustment of therapy as needed.
Note: You must remain under the care of your oncologist and continue all recommended standard-of-care therapies. We coordinate with your medical team when possible.
Potential Benefits & Limitations
Possible Benefits (based on clinical experience and published reports)
-
Reduced chemotherapy-related side effects (e.g. nausea, fatigue, neuropathy)
-
Improved treatment tolerance
-
Supporting immune resilience
-
Decreased oxidative stress / inflammation
-
Enhanced patient-reported quality of life
Important Limitations & Warnings
-
This is not a standalone cancer treatment
-
Not all patients respond similarly
-
There is limited large-scale randomized clinical trial evidence for many cancer types
-
Some risks exist (e.g. in renal impairment, G6PD deficiency) — that is why screening is required
-
Always maintain open communication with your oncologist
Adjunctive therapy to support cancer patients undergoing conventional treatment.
-
Reduces Treatment-Related Fatigue
-
Supports Immune Function
-
Improves energy levels/fatigue
-
Decreases Inflammation & Oxidative Stress
-
Promotes Healing & Recovery
-
Improves Tolerance of Conventional Therapies
-
Enhances Nutrient & Antioxidant Levels
-
May Support Tumor Microenvironment Balance
-
Improves Overall Quality of Life
IVC can help restore depleted nutrient levels and improve cellular energy metabolism, reducing fatigue often experienced during and after cancer therapy.
Vitamin C supports the production and activity of white blood cells, helping the immune system stay resilient during chemotherapy, radiation, or recovery phases.
Energy and Fatigue Relief: Some individuals report increased energy and reduced fatigue following IV vitamin C treatments, particularly if they were deficient in vitamin C.
High-dose IVC helps neutralize free radicals and reduce systemic inflammation — both of which are heightened during cancer treatments and can contribute to tissue damage and fatigue.
Vitamin C is essential for collagen synthesis and tissue repair. IV delivery accelerates wound healing after surgery, radiation burns, or treatment-related tissue injury.
Patients receiving IVC often report fewer side effects from chemotherapy or radiation, including nausea, malaise, and neuropathy. This can enhance quality of life and support adherence to prescribed oncology regimens.
IV administration achieves blood concentrations far higher than oral intake, helping replenish vitamin C stores quickly and effectively — especially when absorption through the digestive tract is compromised.
At pharmacologic doses, IV Vitamin C may act as a pro-oxidant in tumor tissue, generating hydrogen peroxide that selectively affects cancer cells while protecting healthy cells through antioxidant pathways.
(Emerging evidence; adjunctive only — not a replacement for standard care.)
Many patients report improved energy, mood, and recovery between treatments — helping maintain strength and wellbeing throughout the cancer journey.
Note: High-Dose IV Vitamin C is provided only as supportive care for patients under active oncology treatment. It is not a substitute for chemotherapy, radiation, or other physician-directed cancer therapies. All treatments are coordinated with your medical team and overseen by qualified clinicians.
Research Studies
Nutrients Research:
https://riordanclinic.org/research-study/high-dose-intraveneous-vitamin-c-and-chikungunya-fever-a-case-report/
Vitamin C and Cancer Research:
Suppression of Inflammation:
https://riordanclinic.org/research-study/high-dose-intravenous-ascorbic-acid/
Study of Vitamin C Pharmacology:
https://riordanclinic.org/research-study/study-vitamin-c-pharmacology/
Mitochondrial Correction: